Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle J Cole

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Sexually Transmitted Diseases|January 13, 2015
Risk factors for antimicrobial-resistant Neisseria gonorrhoeae in EuropeMichelle J Cole, Gianfranco Spiteri, Katy Town, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2010
An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in EuropeStephanie A Chisholm, Nerteley Quaye, Michelle J Cole, et al.
BMC Medical Research Methodology|July 2, 2025
Evaluating blood sampling strategies within the SIREN study: the experience from a large cohort of healthcare workers in the UKNipunadi Hettiarachchi, Debbie Blick, Tom Coleman, et al.
BMC Infectious Diseases|June 7, 2022
Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019Michaela J Day, Susanne Jacobsson, Gianfranco Spiteri, et al.
BMC Infectious Diseases|June 18, 2020
Sensitivity, specificity, inclusivity and exclusivity of the updated Aptima Combo 2 assay, which provides detection coverage of the new diagnostic-escape Chlamydia trachomatis variantsMagnus Unemo, Marit Hansen, Ronza Hadad, et al.
The Lancet. Microbe|June 6, 2022
Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance studyLeonor Sánchez-Busó, Michelle J Cole, Gianfranco Spiteri, et al.
The Lancet. Microbe|May 11, 2022
WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational studyMagnus Unemo, Monica M Lahra, Martina Escher, et al.
International Journal of STD & AIDS|March 24, 2026
Key findings from the 2024 <i>Mycoplasma genitalium</i> Antimicrobial Resistance Surveillance (MARS) programmeKirsty F Bennet, James E C Johnson, Sandhya Vivekanand, et al.
The Lancet. Microbe|September 27, 2025
WHO global gonococcal antimicrobial surveillance programmes, 2019-22: a retrospective observational studyMagnus Unemo, Monica M Lahra, Michelle J Cole, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 2019
Gentamicin, azithromycin and ceftriaxone in the treatment of gonorrhoea: the relationship between antibiotic MIC and clinical outcomeMichelle J Cole, Wei Tan, Helen Fifer, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Sexually Transmitted Diseases|January 13, 2015
Risk factors for antimicrobial-resistant Neisseria gonorrhoeae in EuropeMichelle J Cole, Gianfranco Spiteri, Katy Town, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2010
An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in EuropeStephanie A Chisholm, Nerteley Quaye, Michelle J Cole, et al.
BMC Medical Research Methodology|July 2, 2025
Evaluating blood sampling strategies within the SIREN study: the experience from a large cohort of healthcare workers in the UKNipunadi Hettiarachchi, Debbie Blick, Tom Coleman, et al.
BMC Infectious Diseases|June 7, 2022
Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019Michaela J Day, Susanne Jacobsson, Gianfranco Spiteri, et al.
BMC Infectious Diseases|June 18, 2020
Sensitivity, specificity, inclusivity and exclusivity of the updated Aptima Combo 2 assay, which provides detection coverage of the new diagnostic-escape Chlamydia trachomatis variantsMagnus Unemo, Marit Hansen, Ronza Hadad, et al.
The Lancet. Microbe|June 6, 2022
Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance studyLeonor Sánchez-Busó, Michelle J Cole, Gianfranco Spiteri, et al.
The Lancet. Microbe|May 11, 2022
WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational studyMagnus Unemo, Monica M Lahra, Martina Escher, et al.
International Journal of STD & AIDS|March 24, 2026
Key findings from the 2024 <i>Mycoplasma genitalium</i> Antimicrobial Resistance Surveillance (MARS) programmeKirsty F Bennet, James E C Johnson, Sandhya Vivekanand, et al.
The Lancet. Microbe|September 27, 2025
WHO global gonococcal antimicrobial surveillance programmes, 2019-22: a retrospective observational studyMagnus Unemo, Monica M Lahra, Michelle J Cole, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 2019
Gentamicin, azithromycin and ceftriaxone in the treatment of gonorrhoea: the relationship between antibiotic MIC and clinical outcomeMichelle J Cole, Wei Tan, Helen Fifer, et al.
Pageof 6